SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Mar 21, 2024
Document Date
Mar 21, 2024
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Aquestive Therapeutics
Issuer
Aquestive Therapeutics, Inc.
Email Alerts
Investor Contact
Investor FAQs
RSS Feeds